Abstract: Pyrimidines of formula I in which R1 represents hydrogen or alkyl, haloalkyl, alkenyl, alkynyl, alkadienyl, alkoxy, cycloalkyl, phenyl, or 5- or 6-membered heteroaryl or 5- or 6-membered heterocyclyl, containing one to four nitrogen atoms or one to three nitrogen atoms and one sulfur or oxygen atom, or tri-alkyl-silyl, formyl or alkoxycarbonyl, wherein R1 groups are unsubstituted or substituted as defined in the specification; R2 represents phenyl, cycloalkyl or 5- or 6-membered heteroaryl, containing one to four nitrogen atoms or one to three nitrogen atoms and one sulfur or oxygen atom, which are unsubstituted or substituted; R3 represents hydrogen, halogen or alkyl, alkoxy, alkylthio, alkylamino or dialkylamino; which are unsubstituted or substituted; R4 represents hydrogen or alkyl, alkenyl or alkynyl; which are unsubstituted or substituted; and X represents O, S, NR5 or a single bond, wherein R5 represents hydrogen or alkyl; or R1 and R5 together with the interjacent nitrogen ato

Abstract: The present invention relates to indolo[3,2-j]phenanthridine compounds and their use in the treatment of cancer and other diseases of humans and animals including parasitic diseases such as those of Apicomplexan origin, compositions containing said compounds and methods of treatment using them.

Abstract: In accordance with the present invention, a novel class of substituted pyridine compounds (optionally containing ether, ester, amide, ketone or thioether substitutions) that promote the release of ligands involved in neurotransmission have been discovered. In a particular aspect compounds of the present invention are capable of modulating acetylcholine receptors. The compounds of the present invention are capable of modulating acetylcholine receptors. Invention compounds may act as agonists, partial agonists, antagonists or allosteric modulators of acetylcholine receptors.

Abstract: The present invention includes compounds of formula I wherein A, X, n, Ar1, and Ar2 are defined as set forth herein. These compounds may be used to treat depression. The invention also includes formulations containing these compounds, and methods for making and using compounds of this invention.

Abstract: Compounds of the formula: where the formula variables are as defined in the disclosure, advantageously inhibit or block the biological activity of the picornaviral 3C protease. These compounds, as well as pharmaceutical compositions containing these compounds, are useful for treating patients or hosts infected with one or more picornaviruses, such as RVP. Intermediates and synthetic methods for preparing such compounds are also described.

Abstract: The present invention is concerned with novel HIV protease Inhibitors of formula I as individual isomers, racemates, non-racemic mixtures or mixtures of diastereoisomers; wherein n, R1 and R4 are as described herein. The compounds of formula I are peptide mimetics which act as inhibitors of the HIV aspartyl protease, an essential enzyme in the replicative life cycle of HIV.

Abstract: Compositions and methods utilizing the optically pure (+) isomer of norcisapride are disclosed. This compound has surprisingly been found to be a potent drug for the treatment of disorders of the central nervous system. The compound, (+) norcisapride, has also been found to be a potent antiemetic agent. Finally, the (+) isomer of norcisapride also avoids certain adverse side effects and certain adverse drug interactions.

Abstract: Compounds of the formula I or a pharmaceutically acceptable salt, solvate or N-oxide thereof, wherein X is ═CH— or ═N—; Y is H, halogen, trihaloalkyl, alkyl, alkenyl, cycloalkyl, cycloalkyl, SH, —S-alkyl, or —CN. R is alkyl, —CF3, cycloalkyl, heterocycloalkyl, heterocycloalkyl-alkyl, heteroarylalky or adamantyl, or optionally substituted phenyl, phenoxyalkyl, phenylthioalkyl, pyridyl, thienyl, thiazolyl, pyrazinyl, 1,2,5,6-tetrahydropyridine or  wherein R10 and R11 are hydrogen, alkyl or together form a cycloalkyl, are disclosed, as well as pharmaceutical compositions and methods of using said compounds in the treatment of eating disorders and diabetes.

Abstract: Thienyl-, furyl- and pyrrolyl-sulfonamides, formulations of pharmaceutically-acceptable salts thereof and methods for modulating or altering the activity of the endothelin family of peptides are provided. In particular, N-(isoxazolyl)thienylsulfonamides, N-(isoxazolyl)furylsulfonamides and N-(isoxazolyl)pyrrolylsulfonamides, formulations thereof and methods using these sulfonamides for inhibiting the binding of an endothelin peptide to an endothelin receptor by contacting the receptor with the sulfonamide are provided. Methods for treating endothelin-mediated disorders by administering effective amounts of one or more of these sulfonamides or prodrugs thereof that inhibit the activity of endothelin are also provided.

Abstract: ACE-2 inhibiting compounds are disclosed. These compounds include compounds of formula (IV): wherein the variables are as described in the specification. Pharmaceutical compositions containing the compounds are also discussed. The pharmaceutical compositions may contain an effective amount of a compound of the invention to treat ACE-2 associated disorders such as a blood pressure related disease or disorder, cell proliferation disorder, kidney disorder, kinetensin associated disorder, inflammation associated disorder, or an allergic disorder.

Abstract: The invention relates to BCAT inhibitors and the use thereof for treating or preventing neuronal loss associated with stroke, ischemia, CNS trauma, hypoglycemia and surgery, as well as treating neurodegenerative diseases including Alzheimer's disease, amyotrophic lateral sclerosis, Huntington's disease and Down's syndrome, treating or preventing the adverse consequences of the overstimulation of the excitatory amino acids, treating anxiety, psychosis, convulsions, aminoglycoside antibiotics-induced hearing loss, migraine headache, chronic pain, neuropathic pain, Parkinson's disease, diabetic retinopathy, glaucoma, CMV retinitis, urinary incontinence, opioid tolerance or withdrawal, and inducing anesthesia, as well as for enhancing cognition.

Abstract: The present invention provides for pharmaceutical compositions comprising carvedilol for treatment of cancer. More particularly the invention relates to the use of carvedilol for treatment of cancers of the colon, ovary, breast, prostate, pancreas, lung, melanoma, glioblastoma, oral cancer and leukemias. Although not bound to any theory, the anticancer activity of carvedilol appears to be attributed to the inhibition of Epidermal Growth Factor and Platelet derived growth factor dependent proliferation of cancer cells. Further, carvedilol exerts anticancer effect by inhibition of the Protein kinase C (PKC) activity and that of the cyclooxygenase 2 enzyme. The invention also relates to the anticancer activity of the optically pure isomers S(−) and R(+) of carvedilol and the use of carvedilol and its isomers in pharmaceutical compositions for the treatment of cancer.

Abstract: The invention relates to novel 2-(2-methylphenyl)-3,4-dihydro-2H-pyrrole derivatives of the formula (I) in which Ar represents substituted phenyl, to a plurality of processes for their preparation and to their use as pesticides.

Abstract: This invention relates to methods, pharmaceutical compositions and kits useful in treating conditions responsive to estrogen by the administration of estrogen agonists/antagonists. Conditions responsive to the compositions and methods include rheumatoid arthritis, colon cancer, tissue wounds, skin wrinkles and cataracts. The compositions are comprised of an estrogen agonist/antagonist and a pharmaceutically acceptable vehicle, carrier or diluent. The compositions and methods of treatment are effective while substantially reducing the concomitant liability of adverse effects associated with estrogen administration.

Abstract: Molecules demonstrating anti-proliferative effects against epithelial cancer cell lines and endothelial cells and methods of synthesis are disclosed. The molecules are intended for use in therapeutic preparations for the treatment of cancer through either anti-angiogenesis or other anti-cancer mechanisms. The compounds specified are 6H-dibenzo[b,d]pyran-6-one derivatives and have been shown to be antiproliferative against human endothelial cells.

Abstract: The present invention relates to a class of carbocyclic compounds of Formula I that are useful as potassium channel inhibitors to treat autoimmune disorders, cardiac arrhythmias, and the like.

Abstract: A composition of selenium monobromide-oil reaction product including a reaction product of selenium momobromide-in-oil prepared from eleostearic acid and selenium monobromide, which contains at least about 0.1 percent of selenium monobromide and exhibits ultraviolet absorption maxima typical of conjugated trienes and conjugated dienes and pharmnaceutical composition thereof for administration to a subject in a therapeutically effective amount to treat neoplastic conditions such as cancer. Methods of making such compositions are also encompassed, as are methods for treating neoplastic conditions by administering to a subject an effective amount of a selenium monobromide-oil reaction product with epichlorohydrin.

Abstract: The use of bissulfonamides for producing medicines for the treatment of hyperlipidemia. The invention relates to the use of bissulfonamides and their salts for producing medicines for the treatment of hyperlipidemia. The use of compounds of formula I in which the radicals have the stated meanings, and of their salts for producing a medicine for the treatment of hyperlipidemia is described.

Abstract: A method and formulation for sterilizing and disinfecting surfaces, and for killing bacteria on contact, the sterilizing and disinfecting formulation containing water and between about 0.0001 percent and about 10.0 percent by weight capsicum, the method and formulation particularly adapted for sterilization and disinfecting food and meat stuffs, and for food and meat processing equipment and facilities.

Abstract: Monoacyl-substituted guanidines of formula III, or a salt or acid thereof, and their use as medicine or diagnostic aid: in which X(2) is

Abstract: Aqueous compositions of nonsteroidal triphenylethylene antiestrogens for pharmaceutical use comprising as a solubility enhancing agent a pharmaceutically acceptable mono- or dicarboxylic acid having 1-5 carbon atoms, wherein the carbon chain may further contain 1-4 hydroxyl, 1-3 oxo, or one or several halogen a substituents, or a corresponding anion thereof, or methanesulfonic acid or its corresponding anion, in molar excess with respect to the triphenylethylene antiestrogen, optionally together with an organic water miscible co-solvent such as polyethylene glycol (PEG), propylene glycol, ethanol or isopropanol.

Abstract: The present invention relates to a dual bronchodilator inhalation solution, system, kit and method for relieving bronchospasm in patients suffering from chronic obstructive pulmonary disease (COPD). In one alternative embodiment, the solution of the present invention is a prepackaged, sterile, premixed, premeasured single unit dose of albuterol and ipratropium bromide for patients suffering from COPD. The present solution may be free of antimicrobial preservatives, such as benzalkonium chloride. In another alternative embodiment, the solution of the present invention comprises about 2.50 mg albuterol and about 0.50 mg ipratropium bromide.

Abstract: This invention relates to the use of a composition for local percutaneous delivery of a drug such as a muscle relaxant, more particularly cyclobenzaprine in an organogel cream. The composition is applied by the patient directly to the skin over accessible muscles of mastication i.e., masseter and temporalis. The composition is rapidly absorbed through the skin to provide control of harmful habits such as bruxism and tooth clenching. The composition can also be applied to the skin overlying these muscles to control muscle hyperactivity (spasm) and/or trigger points, from other causes. The composition can be formulated to include another active agent such as a non-steroidal anti-inflammatory, for example ketoprofen.

Abstract: The invention relates to methods and compositions for preserving blood samples. In particular, a method for stabilizing glucose level in a blood sample is provided, which method comprises adding an effective amount of glyceraldehyde to a blood sample, whereby glucose level in said blood sample remains substantially constant for a period of time. Kits and combinations for stabilizing glucose level in a blood sample are also provided.

Abstract: A method for improving muscle control, muscle tone, and sensory integration of an individual by applying polyacrylamide gel to the skin overlying the target muscles. A reflex response by the muscles to the temperature of the polyacrylamide gel is desired which improves the individual's control of the muscle, the tone of the individual's muscles, and stimulates the central nervous system positively. Resistance can be optionally applied to the reflex response of the muscles, further reinforcing the treatment and promoting the individual to gain muscle control and improve muscle tone.

Abstract: A plant for manufacturing urea from carbonaceous materials, oxygen from an air separation unit and water, preferably steam, is made up of a syngas generator unit, an air separation unit, Fischer-Tropsch unit, a CO2 removal unit, a hydrogen removal unit, a methanator unit, an ammonia converter unit and a urea synthesizer unit. Each of Fischer-Tropsch liquids, ammonia, hydrogen and urea can be recoverable under proper economic conditions. Electrical power is recoverable by the addition of at least one of a steam turbine and a gas turbine which is/are coupled to an electrical generator.

Abstract: Polymer composition, membrane comprising the same, process for production thereof and use thereof The composition described comprises 30 to 99.5% by weight of a sulfonated aromatic polyether ketone which has an ion-exchange capacity of from 1.3 to 4.0 meq (—SO3H)/g of polymer, and from 0.5 to 70% by weight of a polybenzimidazole. This composition can, as can a sulfonated polyether ketone of PEK type, be processed to give membranes, preferably used in fuel cells.

Abstract: A heterogeneous anion exchanger comprising from 35 to 85 mass % of an anion exchange resin and from 15 to 65 mass % of a binder polymer, wherein the anion exchange resin is made of a polymer having repeating units represented by the following formula (1): wherein R is a C3-8 alkylene group or an alkyleneoxyalkyl group having a total carbon number of from 4 to 9, R1 is a C1-4 alkyl group which may be substituted by a hydroxyl group, each of R2 and R3 is a C1-4 alkyl group, and X− is an anion, and wherein any hydrogen atom bonded to the benzene ring may be substituted by an alkyl group or a halogen atom.

Abstract: A porous carbonized film with fine continuous pores, obtained by carbonization of a highly heat-resistant resin porous film in an anaerobic atmosphere, and a process for its production.

Abstract: Microporous materials and articles are disclosed. The microporous materials contain a crystallizable propylene-containing polymer, a beta-nucleating agent, and a diluent that is miscible with the polymer at a temperature above the melting temperature of the polymer and that phase separates from the polymer at a temperature below the polymer crystallization temperature. The invention is also directed to methods of forming the microporous material using thermal induced phase separation and subsequent processing.

Abstract: This invention relates to flame-laminable polyurethane block foams having high peel strength, a process for their production and the use thereof for textile lamination.

Abstract: A self-leveling finishing composition capable of providing chemically resistant low profile coatings is described. The finishing composition comprises thermoplastic resin solids and thermosetting resin solids in a weight ratio of about 0.5:1 to about 11:1 and a solvent composition comprising a solvent capable of dissolving the thermoplastic resin solids component and a solvent miscible co-solvent capable of dissolving the thermosetting resin solids. The finishing composition is applied and dried to a dry-to-touch surface which is thereafter subjected to conditions capable of initiating polymerization of the component thermosetting resin solids. The finishing composition can be used as a substitute for more expensive or more labor intensive coating compositions in existing surface finishing protocols without compromise of surface quality and chemical resistance.

Abstract: Dental composites containing hybrid fillers and process for their production. Dental compounds are disclosed which contain two- or multi-phase inorganic fillers in an organic polymer matrix. These are characterized by improved abrasion resistance.

Abstract: A process for producing polypropylene having increased melt strength, the process comprising irradiating polypropylene with an electron beam having an energy of at least 5 MeV and with a radiation dose of from 5 to 100 kGray in the presence of a grafting agent for forming long chain branches on the polypropylene molecules.

Abstract: A plastics material comprises an acrylic polymer containing 5-50% of a rubbery copolymer and a biocidal compound. The plastic material is useful as a component of a refrigerator, worktop etc. or as a building material. The material may be used as a coating for a substrate. Method of manufacturing laminate materials comprising the plastics material are also claimed.

Abstract: This invention relates to a polyurethane-forming no-bake foundry binder comprising a (a) polyether polyol component comprising (1) a polyether polyol, (2) hydrofluoric acid, and (3) an aminoalkoxysilane, (b) a polyisocyanate component, (c) a liquid tertiary amine catalyst component. Foundry mixes are prepared by mixing the binder system with a foundry aggregate by a no-bake process. The resulting foundry shapes are used to cast metal parts from ferrous and non-ferrous metals.

Abstract: A friction material comprising a fibrous reinforcement, a friction modifier, and a binder. An abrasive component of the friction material includes non-fibrous particulate matters having the same material as fibrous matters of rock wool, slag wool, and ceramics including Al2O3—SiO2 as a main component, but the fibrous matters are not contained.

Abstract: The invention relates to polyurethanes, inks comprising polyurethanes and their use in ink jet printing where the polyurethane comprises a colored water-dissipatable polyurethane obtainable from the reaction of a polyisocyanate, a compound providing water-dispersing groups and a colorant having at least two functional groups.

Abstract: The specification discloses improved alkyd-based ink vehicles for lithographic inks. An ink vehicle according to the invention may contain a rosin ester resin, an ink solvent and from about 1 to about 30% by weight alkyd resin comprising the reaction product of a monounsaturated cyclic diacid anhydride, a polyol and a tall oil fatty acid. The ink vehicle enables faster ink drying and improved pigment wetting without significant adverse affects on other properties of ink formulations such as misting and volatility.

Abstract: A process for coating a solid surface comprises 1) applying onto a solid surface a primer coating prepared from an amine curing agent, a polysulfide toughening agent, an epoxy resin, a rubber toughening agent, a fire retardant, a glass fiber thixotrope, and a pigment; and 2) applying onto the primer coating a topcoat prepared from an amine curing agent, a polysulfide toughening agent, an epoxy resin, a rubber toughening agent, a fire retardant, a glass fiber thixotrope, a pigment and an abrasive aggregate.

Abstract: Self-leveling screeds and trowel-applied flooring compositions are provided containing dispersion powder compositions based on vinylaromatic-1,3-diene copolymers. The use of these copolymers in the flooring compositions dispensing with the need for fully hydrolyzed copolymers made from 1-alkylvinyl esters and from vinyl esters while obtaining good wear resistance, scratch resistance and adhesion.

Abstract: A polymer composition includes a first component being a hydroxy-functional polymer, a second component being a natural polymer and a third component being a thermoplastic polyester. The first component, second component and third component are compounded to form a polymer composition.

Abstract: A cellulose/polyolefin pellet comprising polyolefin material and cellulosic material. The pellet may be concentrated such that it contains less than about 20% by weight of the polyolefin material and at least about 55% by weight of the cellulosic material. The pellet may be shipped to a remote manufacturing location where it may be blended with additional polyolefin material to make a synthetic wood component.

Abstract: A method of using an extrudable thermoplastic compositions that contains a mixture of benzotriazoles is disclosed. The composition is suitable for producing sheets having improved surface quality.

Abstract: The present invention provides: a production process for an aqueous coating composition including a resin emulsion, which has excellent storage stability, and besides, excellent sagging performance, adhesion and water resistance. The production process for an aqueous coating composition comprises the steps of: beforehand mixing 20 to 50 parts by weight of an aqueous acrylic resin solution with 100 parts by weight of a resin emulsion, wherein the aqueous acrylic resin solution and the resin emulsion are in a state of not including an organic solvent; and adding an organic solvent to a mixed liquid obtained by mixing the resin emulsion and the aqueous acrylic resin solution.

Abstract: A thermoplastic molding composition that contains an aliphatic thermoplastic polyurethane (TPU) resin is disclosed. The TPU is the product of a reaction of A) a diisocyanate reactant that contains predominantly hexamethylene diisocyanate, and B) a polyol reactant that contains polytetramethylene glycol and C) a chain extending reactant that contains primarily 1,6-hexanediol. The TPU that is further characterized in the equivalence ratio of A to B and NCO index exhibits improved properties.

Abstract: An adhesive caulking material comprising granular solid colored particles dispersed in a base formulation is disclosed. The adhesive caulking material exhibits a cosmetic capacity to take on the appearance of a natural or synthetic solid substrate. A method is provided for producing the adhesive caulking material comprising the steps of: (a) providing a base formulation exhibiting a desired background color; and (b) adding to the base formulation an amount of granular solid colored particles effective to achieve a desired appearance. The invention also relates to colored solid chips comprising a coagulated or aggregated mixture comprising a polymeric resin and an amount of one or more pigments sufficient to obtain a desired single- or multi-colored appearance. The chips have a granular shape and have a size in the range from about 0.25 mm to about 20 mm in diameter.

Abstract: A nanocomposite concentrate composition comprising about 10 weight percent to about 90 weight percent of a layered silicate material and about 10 weight percent to about 90 weight percent of a matrix polymer comprising about 90-99.8% by weight of a polyolefin and about 0.2% to about 10%, preferably about 0.2% to about 3%, more preferably about 1% to 3% by weight, of a maleic anhydride-modified polyolefin, based on the total weight of polyolefins, wherein the layered silicate material is dispersed uniformly throughout the matrix polymer. Shearing of the concentrate and later (after shear) addition of an added matrix polymer avoids thermal degradation of the added matrix polymer and optimizes the dispersion of the nanomer throughout the matrix polymer; provides increased tensile strength; and reduces degradation of the polymer by melt formation of a concentrate thereby decreasing heat degradation of added matrix polymer.

Abstract: A process for preparing copolymers based on vinyl esters and ethylene and, if desired, further comonomers in the form of their aqueous dispersions, having a solids content of greater than 65% and a Brookfield viscosity (20 s−1) of less than 10,000 mPa·s, by means of free-radically initiated polymerization of one or more monomers selected from vinyl esters and ethylene and, if desired, further monomers copolymerizable therewith, in the presence of one or more protective colloids, polymerization being conducted in the presence of from 2 to 15% by weight of seed latex, based on the amount of vinyl ester, said process comprising a) polymerizing without adding emulsifier, and in the presence of one or more polyvinyl alcohols protective colloids having a degree of hydrolysis of from 80 to 95 mol % and a Höppler viscosity in 4% strength aqueous solution of from 3 to 30 mPa·s, and b) introducing the seed latex in a fraction of from 30 to 75% by weight before beginning the polymerization and

Abstract: Flame-retarded transparent plastic compositions comprising polyhalgenated trimethylphenyl indan. The polyhalogenated trimethylphenyl indan is a mixture of polyhalogenated trimethylphenyl indanes having each 3 to 9 halogen atoms. The halogen may be bromine or a mixture of bromine and chlorine. The transparent plastic is selected from polycarbonate, polymethylmethacrylate, and polystyrene. The polyhalogenated trimethylphenyl indan is present in an amount of up to about 40% by weight. The transparent plastic flame-retarded material is prepared by mixing the plastic matrix with a flame-retardant effective amount of a polyhalogenated trimethylphenyl indan.